Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 1, 2019 Off

LineaRx Receives Multiple Purchase Orders for Linear DNA for Use in Therapeutic Development

By BusinessWire

Orders Reflect Growing Interest across the Biotech Industry for Bacteria-Free, Plasmid-Free Therapies STONY BROOK, N.Y.–(BUSINESS WIRE)–$apdn #biotech–LineaRx, Inc., a wholly-owned…

July 1, 2019 Off

Instem Awarded EU Horizon 2020 Research Grant

By BusinessWire

Instem Company NOTOCORD Secures Portion of €4m Grant as Member of Exclusive Scientific Consortium Helping to Make Medications Safer CONSHOHOCKEN,…

July 1, 2019 Off

BIO Announces 2019 Start-up Stadium Winners

By BusinessWire

Annual competition takes place during BIO’s International Convention WASHINGTON, D.C.–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) today announced winners of the…

July 1, 2019 Off

$17.9 bn Pharmaceutical Contract Packaging Market – Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Contract Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added…

Tiziana Life Science reports finding, Intravenous Treatment with Humanized Anti-CD3 mAb slows Type 1 Diabetes
July 1, 2019 Off

Tiziana Life Science reports finding, Intravenous Treatment with Humanized Anti-CD3 mAb slows Type 1 Diabetes

By BusinessWire

Independent third party Phase 2 results show Teplizumab, a mouse derived humanized anti-CD3 monoclonal antibody (mAb) significantly slowed progression of…

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study
July 1, 2019 Off

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study

By BusinessWire

First clinical study of a rationally-defined bacterial consortium (VE416) for treating food allergy, will initially be studied in patients with history of peanut allergy

July 1, 2019 Off

Teva Announces Launch of 1% Sodium Hyaluronate in the United States

By BusinessWire

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of 1% Sodium Hyaluronate. The product received…

July 1, 2019 Off

Abveris and Harbour Antibodies H2L2 BV Announce Technology Co-Offering Agreement for Fully Human Antibody Discovery

By BusinessWire

CANTON, Mass. & CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands–(BUSINESS WIRE)–Abveris, Inc., a global leader in contract research antibody discovery, and…

July 1, 2019 Off

Pfizer Announces Positive Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis

By BusinessWire

Data show crisaborole ointment, 2%, a steroid-free topical treatment, was well-tolerated over 4-week treatment period Safety profile consistent with previous…

July 1, 2019 Off

Soleo Health Ranks Sixth on Dallas Business Journal’s Annual Middle Market 50 List

By BusinessWire

List Showcases Dallas’ Fastest-growing Middle Market Companies McKINNEY, Texas–(BUSINESS WIRE)–#SoleoHealthRanks6DBJMidMarket—Soleo Health, an innovative leader in specialty infusion services, announced today…

Posts pagination

Previous 1 … 3,034 3,035 3,036 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine